COVID-19 discharge and follow-up recommendations.

Abdelnabi, Mahmoud; Leelaviwat, Natnicha; Eshak, Nouran; Mekraksakit, Poemlarp; Nugent, Kenneth; Payne, J Drew

Abdelnabi, Mahmoud; Leelaviwat, Natnicha; Eshak, Nouran; Mekraksakit, Poemlarp; Nugent, Kenneth; Payne, J Drew.

Afiliación

Abdelnabi M; Cardiology and Angiology Unit, Department of Clinical and Experimental Internal Medicine, Medical Research Institute, Alexandria University, Alexandria, Egypt.
Leelaviwat N; Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Eshak N; Department of Internal Medicine, Texas Tech University Health Science Center, Lubbock, Texas.
Mekraksakit P; Department of Internal Medicine, Texas Tech University Health Science Center, Lubbock, Texas.
Nugent K; Department of Internal Medicine, Texas Tech University Health Science Center, Lubbock, Texas.
Payne JD; Department of Internal Medicine, Texas Tech University Health Science Center, Lubbock, Texas.

Proc (Bayl Univ Med Cent) ; 34(1): 73-75, 2020 Oct 30.

Article en En | MEDLINE | ID: mdl-33456149

Palabras clave

Anticoagulation; COVID-19 discharge recommendations; corticosteroid therapy; follow-up; oxygen therapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Proc (Bayl Univ Med Cent) Año: 2020 Tipo del documento: Article País de afiliación: Egipto Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google